BioStem Technologies, Inc. (OTC: BSEM), a leading MedTech company focused on the development, manufacturing, and commercialization of placental-derived products for advanced wound care, announces the closing of a definitive asset purchase agreement with BioTissue Holdings Inc, a pioneer and leader in regenerative healing, whereby BioStem acquired the BioTissue surgical and wound care business. Through this transaction, BioStem acquired the full portfolio of assets associated with BioTissue’s surgical and wound care business, including the Neox® and Clarix® product lines. This acquisition includes the commercial infrastructure associated with the surgical and wound care business.
Read the full article: BioStem Technologies Advances Entry into the Acute Wound Care Market with Acquisition of BioTissue Holdings’ Surgical and Wound Care Business //
Source: https://www.globenewswire.com/news-release/2026/01/21/3223302/0/en/BioStem-Technologies-Advances-Entry-into-the-Acute-Wound-Care-Market-with-Acquisition-of-BioTissue-Holdings-Surgical-and-Wound-Care-Business.html